Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | BCHE | P06276 | 3/20 | 0.51 |
| ▸ | ACHE | P22303 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28346088 | 0.98 | LMNA (0.53) | LMNAL3MBTL1KDM4EBCHEACHE | |
| SCHEMBL212272 | 0.90 | AKR1B1 (0.52) | LMNATDP1ALDH1A1CA12TSHR | |
| SCHEMBL186172 | 0.88 | MEP1B (0.50) | LMNATDP1ALDH1A1CA12 | |
| Ammonia Solution, Strong SCHEMBL27504556 | 0.86 | MEP1B (0.49) | LMNATDP1ALDH1A1CA12 | |
| SCHEMBL8415629 | 0.85 | LMNA (0.51) | LMNAL3MBTL1KDM4EBCHEACHE | |
| SCHEMBL5541857 | 0.85 | RORC (0.56) | LMNABCHEACHECA12TSHR | |
| SCHEMBL16520408 | 0.85 | NPC1 (0.47) | LMNAL3MBTL1BCHEACHEALDH1A1 | |
| SCHEMBL11586184 | 0.84 | MEP1B (0.47) | LMNATDP1ALDH1A1CA12 | |
| SCHEMBL2799777 | 0.84 | TDP1 (0.52) | LMNAKDM4ETDP1ALDH1A1CA12 | |
| SCHEMBL2284795 | 0.82 | TDP1 (0.56) | LMNAKDM4ETDP1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005569-B | 6-Aminoquinoxaline compound and preparation method and application thereof | 华南理工大学 | 2026-05-19 | — | — | CN | claimed |
| EP-3994238-B1 | LUBRICATING COMPOSITIONS CONTAINING BASIC ASHLESS ADDITIVES | LUBRIZOL CORP (US) | 2024-03-13 | — | — | EP | claimed |
| CN-110734393-B | Preparation method of N-benzyl-3-oxopiperidine-4-carboxylic acid ethyl ester hydrochloride | 南京恒远科技开发有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-110734393-A | Preparation method of N-benzyl-3-oxopiperidine-4-carboxylic acid ethyl ester hydrochloride | 南京恒远科技开发有限公司 | 2020-01-31 | — | — | CN | claimed |
| CN-110698356-A | Preparation and purification method of N-benzyl glycine ethyl ester | 南京恒远科技开发有限公司 | 2020-01-17 | — | — | CN | claimed |
| US-20130165446-A1 | BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE | HORIKOSHI, HIROYOSHI (CA) | 2013-06-27 | — | — | US | claimed |
| EP-2581373-A1 | BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE | Fujita, Takashi (JP) | 2013-04-17 | — | — | EP | claimed |
| CN-118005569-B | 6-Aminoquinoxaline compound and preparation method and application thereof | 华南理工大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-118005569-A | 6-Aminoquinoxaline compound and preparation method and application thereof | 华南理工大学 | 2024-05-10 | — | — | CN | disclosed |
| WO-2023226902-A1 | PREPARATION METHOD FOR KRAS G12C INHIBITOR AND INTERMEDIATE THEREOF | 苏州泽璟生物制药股份有限公司 | 2023-11-30 | — | — | WO | disclosed |
| CN-109384778-B | Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder | 赛克里翁治疗有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-115368383-A | Condensed nitrogen-containing heterocyclic compound, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-110016020-B | Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof | 赛克里翁治疗有限公司 | 2022-07-26 | — | — | CN | disclosed |
| WO-2002064547-A2 | ISOPHTHALIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2001046200-A1 | NOVEL PIPERIDINE AND PIPERAZINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-06-28 | — | — | WO | disclosed |
| US-5221665-A | N-substituted amides | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1993-06-22 | — | — | US | disclosed |
| EP-0369391-A2 | N-substituted amides | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1990-05-23 | — | — | EP | disclosed |
| US-4534904-A | Process for producing N-phosphonomethylglycine | CIBA-GEIGY CORPORATION (US) | 1985-08-13 | — | — | US | disclosed |
| US-4486358-A | Process for producing N-phosphonomethylglycine | CIBA-GEIGY CORPORATION (US) | 1984-12-04 | — | — | US | disclosed |
| US-4369142-A | Process for producing N-phosphonomethylglycine | CIBA-GEIGY CORPORATION (US) | 1983-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165446-A1 | BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE | PPARG, PPARA, PPARD | LMNA 3164/4885L3MBTL1 3137/4885KDM4E 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.